Press Releases

Title	Topic	Date
Novavax to Participate in Fireside Chat at Goldman Sachs Virtual Conference		4/8/2021
Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover		4/5/2021
Novavax CEO Stan Erck to Participate in Longwood Healthcare Leaders Meeting		4/5/2021
GSK to support manufacture of Novavax' COVID-19 vaccine		3/29/2021
Novavax Confirms High Levels of Efficacy Against Original and Variant COVID-19 Strains in United Kingdom and South Africa Trials	COVID-19	3/11/2021
Novavax to Participate in H.C. Wainwright Virtual Global Life Sciences Conference Fireside Chat	Corporate and Finance	3/8/2021
Novavax Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights	Corporate and Finance	3/1/2021
Novavax and Takeda Finalize License Agreement for Novavax’ COVID-19 Vaccine Candidate in Japan; Takeda Initiates Phase 1/2 Trial in Japan	COVID-19	2/26/2021
Novavax Completes Enrollment of PREVENT-19, COVID-19 Vaccine Pivotal Phase 3 Trial in the United States and Mexico	COVID-19	2/22/2021
Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine	COVID-19	2/18/2021